Adults with JIA: It ain’t all child’s play https://t.co/z3xDjKH2ru https://t.co/9DDGYdpMSr

• https://bit.ly/3P9XowF

New podcast up—“What Worries You, Masters You” We review recent news, regulatory and guideline updates from the past week. Studies on MTX use, COVID vaccination, Supplements and vitamins, and arthrocentesis despite anticoagulation are discussed. https://t.co/jRaLCQAt9K https://t.co/opa22JqU41

• https://bit.ly/3umGov9

Exercise and fibromyalgia? Metanalysis of 18 studies & 1184 pts, comparing aerobic, resistance & stretching. All 3 had large & significant effect on pain (not diff from each other); also improves QOL (possibly depression) https://t.co/RYba99OWCh https://t.co/izpHjeXWCt

• https://go.nature.com/3bD5LSJ

EMA has approved Secukinumab for the expanded approvals for use in pediatric patients with enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) . Approvals based on the JUNIPERA trial, showing reduced the risk of flare & Dz activity w/ SEC https://t.co/6pWc6nEUd9 https://t.co/gGGyzEEh0u

• https://bit.ly/3yxFmyP

Inferior IL-17 Inhibitor Responses in Psoriatic Women Pooled data from two large (IXE trials show that male patients had greater clinical responses than did female patients with PsA are largely unexplored. Reasons for this is unexplained. https://t.co/OAu6gCweDt https://t.co/lsM6hZUwNQ

• https://bit.ly/3NE5Ov1

Study of IV CTX (n 13) vs mepolizumab (n 7)(MPZ; IL-5 inhib) in severe eosinophilic granulomatosis polyangiitis. BVAS & EOS# equal at mo 1 & 6, but MPZ had better retention(61 vs 5%) & less AEs (29% vs 54%) https://t.co/7s38a67C1r https://t.co/oXLb1ctoc7

• https://bit.ly/3Alt3a1

New Updated GRAPPA Psoriatic Arthritis Recommendations The GRAPPA treatment recommendations have been updated and the 2021 evidence-based guidance is rich in treatment recommendations based on the key disease "domains." A great reference to print & carry. https://t.co/0K8LP3LA9j https://t.co/1fJlzPKLWl

• https://bit.ly/3ujLM1R

JAMA Clinical Review 15 min podcast on treatment of carpal tunnel syndrome and trigger finger and common hand problems in clinical practice; featuring Drs. Mary M. McDermott, and Kelly Currie https://t.co/IhD6iqVyqC https://t.co/aChPLIbuEu

• https://bit.ly/3ufH6dC

The EMA's CHMP has positively recommended upadacitinib for use in Non-radiographic axial spondyloarthritis (nr-axSpA) based on Phase 3 SELECT-AXIS 2 study showing superior ASAS40 responses at week 14 https://t.co/uc7oOKglLX https://t.co/yz7M8U3rkk

• https://bit.ly/3uldc7M

JAMA Patient Page on "What is Carpal Tunnel Syndrome ? A great patient resource, full read with graphics https://t.co/lL9209YpdL https://t.co/28ceu2obma

• https://bit.ly/3NAJ66T

🆕🚨Possible future avenues for myositis therapeutics: DM,IMNM&IBM Current treatment options in IIM management 1st line:GC+ Skin➡️MTX/AZR/MMF Muscle➡️AZR/MMF/MTX Lung➡️AZR/MMF Dysphagia/Diaphragmatic weakness➡️IVIG RP-ILD➡️IVIG+CNI+CYC/RTX Calcinosis➡️JAKi https://t.co/G3vN055Gyq https://t.co/Qy9MULgeMs

• URL Shortener